Biomaterials and cells for cardiac tissue engineering

Cardiac Regeneration and Repair: Biomaterials and Tissue Engineering

Volumn , Issue , 2014, Pages 127-179

  Vu, T D ^a   Kofidis, T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomaterials; Cardiac tissue engineering; Cells; Myocardial infarction; Scaffolds

Indexed keywords

EID: 84903264894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857096715.2.127     Document Type: Chapter

References (252)

1. Ahmed T.A., Dare E.V., Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev. 2008, 14:199-215.
2. Aicher A., Brenner W., Zuhayra M., Badorff C., Massoudi S., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003, 107:2134-2139.
3. Almany L., Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials. 2005, 26:2467-2477.
4. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005, 102:11474-11479.
5. Amir G., Miller L., Shachar M., Feinberg M.S., Holbova R., et al. Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transplant. 2009, 18:275-282.
6. Amsalem Y., Mardor Y., Feinberg M.S., Landa N., Miller L., et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007, 116:I38-I45.
7. Anderson K.R., Sutton M.G., Lie J.T. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol. 1979, 128:79-85.
8. Anversa P., Olivetti G., Capasso J.M. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol. 1991, 68:7D-16D.
9. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 2009, 5:1-13.
10. Bai X.P., Zheng H.X., Fang R., Wang T.R., Hou X.L., et al. Fabrication of engineered heart tissue grafts from alginate/collagen barium composite microbeads. Biomed Mater. 2011, 6:045002.
11. Barash Y., Dvir T., Tandeitnik P., Ruvinov E., Guterman H., Cohen S. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng Part C Methods. 2010, 16:1417-1426.
12. Bel A., Planat-Bernard V., Saito A., Bonnevie L., Bellamy V., et al. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation. 2010, 122:S118-S123.
13. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003, 114:763-776.
14. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., et al. Evidence for cardiomyocyte renewal in humans. Science. 2009, 324:98-102.
15. Bernstein H.S. Cardiac repair and restoration using human embryonic stem cells. Regen Med. 2012, 7:697-712.
16. Bhana B., Iyer R.K., Chen W.L., Zhao R., Sider K.L., et al. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng. 2010, 105:1148-1160.
17. Bian W., Liau B., Badie N., Bursac N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc. 2009, 4:1522-1534.
18. Blin G., Nury D., Stefanovic S., Neri T., Guillevic O., et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest. 2010, 120:1125-1139.
19. Brown M.A., Iyer R.K., Radisic M. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog. 2008, 24:907-920.
20. Buckberg G.D. Basic science review: the helix and the heart. J Thorac Cardiovasc Surg. 2002, 124:863-883.
21. Camelliti P., Green C.R., Kohl P. Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol. 2006, 42:132-149.
22. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng. 1999, 64:580-589.
23. Chachques J.C., Trainini J.C., Lago N., Cortes-Morichetti M., Schussler O., Carpentier A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg. 2008, 85:901-908.
24. Chachques J.C., Trainini J.C., Lago N., Masoli O.H., Barisani J.L., et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant. 2007, 16:927-934.
25. Chen C., Ma L., Dyckman W., Santos F., Lai T., et al. Left ventricular remodeling in myocardial hibernation. Circulation 1997, 96(II):46-50.
26. Chen Q.Z., Ishii H., Thouas G.A., Lyon A.R., Wright J.S., et al. An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials. 2010, 31:3885-3893.
27. Chen S.L., Fang W.W., Qian J., Ye F., Liu Y.H., et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Engl). 2004, 117:1443-1448.
28. Chiu L.L., Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials. 2010, 31:226-241.
29. Chiu L.L., Reis L.A., Momen A., Radisic M. Controlled release of thymosin beta4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction. Regen Med. 2012, 7:523-533.
30. Chiu L.L., Weisel R.D., Li R.K., Radisic M. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med. 2011, 5:69-84.
31. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004, 10:403-409.
32. Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 2004, 44:654-660.
33. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000, 35:569-582.
34. Cohn J.N., Ferrari R., Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000, 35:569-582.
35. Cristallini C., Gagliardi M., Barbani N., Giannessi D., Guerra G.D. Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling. J Mater Sci Mater Med. 2012, 23:205-216.
36. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005, 46:714-719.
37. Davis D.R., Stewart D.J. Autologous cell therapy for cardiac repair. Expert Opin Biol Ther. 2011, 11:489-508.
38. Davis M.E., Motion J.P., Narmoneva D.A., Takahashi T., Hakuno D., et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation. 2005, 111:442-450.
39. Dawn B., Tiwari S., Kucia M.J., Zuba-Surma E.K., Guo Y., et al. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells. 2008, 26:1646-1655.
40. Dixon J.A., Spinale F.G. Myocardial remodeling: cellular and extracellular events and targets. Annu Rev Physiol. 2011, 73:47-68.
41. Dobner S., Bezuidenhout D., Govender P., Zilla P., Davies N. A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. J Card Fail. 2009, 15:629-636.
42. Dorn G.W., Robbins J., Sugden P.H. Phenotyping hypertrophy: eschew obfuscation. Circ Res. 2003, 92:1171-1175.
43. Dvir T., Kedem A., Ruvinov E., Levy O., Freeman I., et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci USA 2009, 106:14990-14995.
44. Efe J.A., Hilcove S., Kim J., Zhou H., Ouyang K., et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol. 2011, 13:215-222.
45. Ellison G.M., Galuppo V., Vicinanza C., Aquila I., Waring C.D., et al. Cardiac stem and progenitor cell identification: different markers for the same cell?. Front Biosci (Schol Ed). 2010, 2:641-652.
46. Engelmayr G.C., Cheng M., Bettinger C.J., Borenstein J.T., Langer R., Freed L.E. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008, 7:1003-1010.
47. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell. 2006, 126:677-689.
48. Epstein J.A., Franklin H. Epstein Lecture. Cardiac development and implications for heart disease. N Engl J Med 2010, 363:1638-1647.
49. Ertl G., Gaudron P., Neubauer S., Bauer B., Horn M., et al. Cardiac dysfunction and development of heart failure. Eur Heart J 1993, 14(Suppl A):33-37.
50. Fernandes S., Naumova A.V., Zhu W.Z., Laflamme M.A., Gold J., Murry C.E. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol. 2010, 49:941-949.
51. Ferrazzi P., Triggiani M., Iacovoni A., Pentiricci S., Vattimo F., et al. Surgical ventricular restoration by means of a new technique to preserve left ventricular compliance: the horseshoe repair. J Thorac Cardiovasc Surg. 2008, 136:1382-1383.
52. Feygin J., Mansoor A., Eckman P., Swingen C., Zhang J. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol. 2007, 293:H1772-H1780.
53. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 2000, 14:669-679.
54. Frederick J.R., Fitzpatrick J.R., Mccormick R.C., Harris D.A., Kim A.Y., et al. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation. 2010, 122:S107-S117.
55. Fujimoto K.L., Ma Z., Nelson D.M., Hashizume R., Guan J., et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials. 2009, 30:4357-4368.
56. Fujita M., Ishihara M., Morimoto Y., Simizu M., Saito Y., et al. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res. 2005, 126:27-33.
57. Gaetani R., Doevendans P.A., Metz C.H., Alblas J., Messina E., et al. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials. 2012, 33:1782-1790.
58. Gaudron P., Eilles C., Kugler I., Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993, 87:755-763.
59. Giannuzzi P., Temporelli P.L., Bosimini E., Gentile F., Lucci D., et al. Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. Am Heart J. 2001, 141:131-138.
60. Giraud M.N., Armbruster C., Carrel T., Tevaearai H.T. Current state of the art in myocardial tissue engineering. Tissue Eng. 2007, 13:1825-1836.
61. Giraud M.N., Flueckiger R., Cook S., Ayuni E., Siepe M., et al. Long-term evaluation of myoblast seeded patches implanted on infarcted rat hearts. Artif Organs. 2010, 34:E184-E192.
62. Gong C., Shi S., Dong P., Kan B., Gou M., et al. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm. 2009, 365:89-99.
63. Goumans M.J., De Boer T.P., Smits A.M., Van Laake L.W., Van Vliet P., et al. TGF-betal induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 2007, 1:138-149.
64. Gu M., Nguyen P.K., Lee A.S., Xu D., Hu S., et al. Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res. 2012, 111:882-893.
65. Gupta M.K., Walthall J.M., Venkataraman R., Crowder S.W., Jung D.K., et al. Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One. 2011, 6:e28935.
66. Habib M., Shapira-Schweitzer K., Caspi O., Gepstein A., Arbel G., et al. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials. 2011, 32:7514-7523.
67. Hamdi H., Furuta A., Bellamy V., Bel A., Puymirat E., et al. Cell delivery: intramyocardial injections or epicardial deposition?. A head-to-head comparison. Ann Thorac Surg. 2009, 87:1196-1203.
68. Haraguchi Y., Shimizu T., Yamato M., Kikuchi A., Okano T. Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomaterials. 2006, 27:4765-4774.
69. Harding S.E., Vescovo G., Jones S.M., Bennett G., Yacoub M., Poole-Wilson P.A. Morphological and functional characteristics of myocytes isolated from human left ventricular aneurysms. J Pathol. 1989, 159:191-196.
70. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods. 2010, 7:61-66.
71. Heusch G., Schulz R. The relation of contractile function to myocardial perfusion Perfusion-contraction match and mismatch. Herz. 1999, 24:509-514.
72. Hochman J.S., Bulkley B.H. Expansion of acute myocardial infarction: an experimental study. Circulation. 1982, 65:1446-1450.
73. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005, 111:2198-2202.
74. Horii T., Tambara K., Nishimura K., Suma H., Komeda M. Residual fibrosis affects a long-term result of left ventricular volume reduction surgery for dilated cardiomyopathy in a rat experimental study. Eur J Cardiothorac Surg. 2004, 26:1174-1179.
75. Huang N.F., Yu J., Sievers R., Li S., Lee R.J. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng. 2005, 11:1860-1866.
76. Hudlicka O., Brown M., Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992, 72:369-417.
77. Hussain A., Collins G., Yip D., Cho C.H. Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds. Biotechnol Bioeng 2013, 110:637-647.
78. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010, 142:375-386.
79. Ieda M., Tsuchihashi T., Ivey K.N., Ross R.S., Hong T.T., et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell. 2009, 16:233-244.
80. Ifkovits J.L., Tous E., Minakawa M., Morita M., Robb J.D., et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA 2010, 107:11507-11512.
81. Iyer R.K., Chiu L.L., Radisic M. Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. J Biomed Mater Res Part A. 2009, 89:616-631.
82. Iyer R.K., Chiu L.L., Radisic M. Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. J Biomed Mater Res A 2009, 89:616-631.
83. Jawad H., Lyon A.R., Harding S.E., Ali N.N., Boccaccini A.R. Myocardial tissue engineering. Br Med Bull 2008, 87L:31-47.
84. Jiang X.J., Wang T., Li X.Y., Wu D.Q., Zheng Z.B., et al. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. J Biomed Mater Res A. 2009, 90:472-477.
85. Jugdutt B.I. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol. 1995, 25:1718-1725.
86. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation. 2003, 108:1395-1403.
87. Kai H. Cardiac remodeling in chronic heart failure. Nihon Rinsho 2006, 64:855-860.
88. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009, 458:771-775.
89. Kawamura M., Miyagawa S., Miki K., Saito A., Fukushima S., et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation. 2012, 126:S29-S37.
90. Keck B.M., Bennett L.E., Rosendale J., Daily O.P., Novick R.J., Hosenpud J.D. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl. 1999, 1999:35-49.
91. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 2001, 108:407-414.
92. Kehat I., Molkentin J.D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010, 122:2727-2735.
93. Kelley S.T., Malekan R., Gorman J.H., Jackson B.M., Gorman R.C., et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation. 1999, 99:135-142.
94. Kim W.G., Park J.K., Moon H.K., Roh J.R. Autologous cardiomyocyte transplantation using a biodegradable polymer scaffold. Int J Artif Organs. 2003, 26:401-405.
95. Kleinman H.K., Mcgarvey M.L., Liotta L.A., Robey P.G., Tryggvason K., Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry. 1982, 21:6188-6193.
96. Klouda L., Mikos A.G. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm. 2008, 68:34-45.
97. Kofidis T. Alternative Cardiac Therapies: Stem Cells and Tissue Engineering for the Heart 2006, CTSNet.
98. Kofidis T., Akhyari P., Boublik J., Theodorou P., Martin U., et al. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg. 2002, 124:63-69.
99. Kofidis T., De Bruin J.L., Hoyt G., Lebl D.R., Tanaka M., et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg. 2004, 128:571-578.
100. Kofidis T., Lebl D.R., Martinez E.C., Hoyt G., Tanaka M., Robbins R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation. 2005, 112:I173-I177.
101. Kofidis T., Lenz A., Boublik J., Akhyari P., Wachsmann B., et al. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials. 2003, 24:5009-5014.
102. Korup E., Dalsgaard D., Nyvad O., Jensen T.M., Toft E., Berning J. Comparison of degrees of left ventricular dilation within three hours and up to six days after onset of first acute myocardial infarction. Am J Cardiol. 1997, 80:44953.
103. Kraehenbuehl T.P., Zammaretti P., Van Der Vlies A.J., Schoenmakers R.G., Lutolf M.P., et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials. 2008, 29:2757-2766.
104. Krupnick A.S., Kreisel D., Engels F.H., Szeto W.Y., Plappert T., et al. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant. 2002, 21:233-243.
105. Kucia M., Reca R., Campbell F.R., Zuba-Surma E., Majka M., et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006, 20:857-869.
106. Kutschka I., Chen I.Y., Kofidis T., Arai T., Von Degenfeld G., et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation. 2006, 114:I167-I173.
107. L'heureux N., Dusserre N., Konig G., Victor B., Keire P., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med. 2006, 12:361-365.
108. Laflamme M.A., Murry C.E. Regenerating the heart. Nat Biotechnol. 2005, 23:845-856.
109. Laflamme M.A., Zbinden S., Epstein S.E., Murry C.E. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol. 2007, 2:307-339.
110. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008, 117:1388-1396.
111. Lee J., Macosko C.W., Urry D.W. Phase transition and elasticity of protein- based hydrogels. J Biomater Sci Polym Ed. 2001, 12:229-242.
112. Lee K.Y., Alsberg E., Mooney D.J. Degradable and injectable poly(aldehyde guluronate) hydrogels for bone tissue engineering. J Biomed Mater Res. 2001, 56:228-233.
113. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem Rev. 2001, 101:1869-1879.
114. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium?. Circulation. 2000, 102:III56-III61.
115. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol. 2009, 54:1014-1023.
116. Lesman A., Habib M., Caspi O., Gepstein A., Arbel G., et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A. 2010, 16:115-125.
117. Levenberg S., Huang N.F., Lavik E., Rogers A.B., Itskovitz-Eldor J., Langer R. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003, 100:12741-12746.
118. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation. 1999, 100:II63-II69.
119. Li R.K., Mickle D.A., Weisel R.D., Carson S., Omar S.A., et al. Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging. Cardiovasc Res. 1996, 32:362-373.
120. Lin Y.D., Yeh M.L., Yang Y.J., Tsai D.C., Chu T.Y., et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation. 2010, 122:S132-S141.
121. Lindsey M.L., Mann D.L., Entman M.L., Spinale F.G. Extracellular matrix remodeling following myocardial injury. Ann Med. 2003, 35:316-326.
122. Lisi A., Briganti E., Ledda M., Losi P., Grimaldi S., et al. A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS One. 2012, 7:e34284.
123. Lu W.N., Lu S.H., Wang H.B., Li D.X., Duan C.M., et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A. 2009, 15:1437-1447.
124. Ly H.Q., Hoshino K., Pomerantseva I., Kawase Y., Yoneyama R., et al. In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. Eur Heart J. 2009, 30:2861-2868.
125. Makela J., Ylitalo K., Lehtonen S., Dahlbacka S., Niemela E., et al. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site. J Thorac Cardiovasc Surg. 2007, 134:565-573.
126. Malliaras K.G., Terrovitis J.V., Drakos S.G., Nanas J.N. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. J Cardiovasc Transl Res. 2009, 2:114-125.
127. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003, 9:1195-1201.
128. Manso A.M., Elsherif L., Kang S.M., Ross R.S. Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling. Cardiovasc Res. 2006, 69:574-584.
129. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008, 29:1807-1818.
130. Martinez E.C., Kofidis T. Myocardial tissue engineering: the quest for the ideal myocardial substitute. Expert Rev Cardiovasc Ther. 2009, 7:921-928.
131. Martinez E.C., Wang J., Gan S.U., Singh R., Lee C.N., Kofidis T. Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivo. Tissue Eng Part A. 2010, 16:1349-1361.
132. Martinez E.C., Wang J., Lilyanna S., Ling L.H., Gan S.U., et al. Post-ischaemic angiogenic therapy using in vivo prevascularized ascorbic acid-enriched myocardial artificial grafts improves heart function in a rat model. J Tissue Eng Regen Med 2011.
133. Masters K.S., Shah D.N., Walker G., Leinwand L.A., Anseth K.S. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A 2004, 71:172-180.
134. Mathieu M., Bartunek J., El Oumeiri B., Touihri K., Hadad I., et al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction. J Thorac Cardiovasc Surg. 2009, 138:646-653.
135. Matsubayashi K., Fedak P.W., Mickle D.A., Weisel R.D., Ozawa T., Li R.K. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation. 2003, 108(Suppl 1):II219-II225.
136. Matsuura K., Honda A., Nagai T., Fukushima N., Iwanaga K., et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest. 2009, 119:2204-2217.
137. Mauritz C., Martens A., Rojas S.V., Schnick T., Rathert C., et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J. 2011, 32:2634-2641.
138. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation. 2008, 118:507-517.
139. Mcdevitt T.C., Woodhouse K.A., Hauschka S.D., Murry C.E., Stayton P.S. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A. 2003, 66:586-595.
140. Mckay R.G., Pfeffer M.A., Pasternak R.C., Markis J.E., Come P.C., et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986, 74:693-702.
141. Menasche P., Alfieri O., Janssens S., Mckenna W., Reichenspurner H., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008, 117:1189-1200.
142. Mitchell G.F., Lamas G.A., Vaughan D.E., Pfeffer M.A. Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol. 1992, 19:1136-1144.
143. Miyagawa S., Sawa Y., Sakakida S., Taketani S., Kondoh H., et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation. 2005, 80:1586-1595.
144. Miyagi Y., Zeng F., Huang X.P., Foltz W.D., Wu J., et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials. 2010, 31:7684-7694.
145. Moller J.C., Schwarz U., Reiss I., Nitsche E. Changes of serum lactate concentration, cardiac output, and heart rate induced by blood transfusions in preterm infants. J Pediatr. 1993, 123:1016-1017.
146. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation. 2007, 115:353-360.
147. Mukherjee R., Zavadzkas J.A., Saunders S.M., Mclean J.E., Jeffords L.B., et al. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg. 2008, 86:1268-1276.
148. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008, 118:498-506.
149. Ng S.Y., Wong C.K., Tsang S.Y. Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol. 2010, 299:C1234-C1249.
150. Okada M., Payne T.R., Oshima H., Momoi N., Tobita K., Huard J. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials. 2010, 31L:7678-7683.
151. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., et al. Apoptosis in the failing human heart. N Engl J Med. 1997, 336:1131-1141.
152. Opie L.H., Commerford P.J., Gersh B.J., Pfeffer M.A. Controversies in ventricular remodelling. Lancet. 2006, 367:356-367.
153. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008, 14:213-221.
154. Ozawa T., Mickle D.A., Weisel R.D., Koyama N., Ozawa S., Li R.K. Optimal biomaterial for creation of autologous cardiac grafts. Circulation. 2002, 106:1176-1182.
155. Ozawa T., Mickle D.A., Weisel R.D., Koyama N., Wong H., et al. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg. 2002, 124:1157-1164.
156. Padin-Iruegas M.E., Misao Y., Davis M.E., Segers V.F., Esposito G., et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009, 120:876-887.
157. Park H., Radisic M., Lim J.O., Chang B.H., Vunjak-Novakovic G. A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev Biol Anim. 2005, 41:188-196.
158. Pearl J.I., Lee A.S., Leveson-Gower D.B., Sun N., Ghosh Z., et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell. 2011, 8:309-317.
159. Pego A.P., VanLuyn M.J., Brouwer L.A., VanWachem P.B., Poot A.A., et al. In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D L-lactide or epsilon-caprolactone: Degradation and tissue response. J Biomed Mater Res A. 2003, 67:1044-1054.
160. Pfeffer M.A., Pfeffer J.M. Ventricular enlargement and reduced survival after myocardial infarction. Circulation. 1987, 75:IV93-IV97.
161. Pilla J.J., Blom A.S., Gorman J.H., Brockman D.J., Affuso J., et al. Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling. Ann Thorac Surg. 2005, 80:2257-2262.
162. Polyakova V., Hein S., Kostin S., Ziegelhoeffer T., Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004, 44:1609-1618.
163. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009, 123:255-278.
164. Potter L.R., Yoder A.R., Flora D.R., Antos L.K., Dickey D.M. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009, 341-366.
165. Radisic M., Euloth M., Yang L., Langer R., Freed L.E., Vunjak-Novakovic G. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng. 2003, 82:403-414.
166. Radisic M., Malda J., Epping E., Geng W., Langer R., Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng. 2006, 93:332-343.
167. Radisic M., Park H., Chen F., Salazar-Lazzaro J.E., Wang Y., et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 2006, 12:2077-2091.
168. Radisic M., Park H., Martens T.P., Salazar-Lazaro J.E., Geng W., et al. Pretreatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res Part A. 2008, 86:713-724.
169. Radisic M., Park H., Shing H., Consi T., Schoen F.J., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004, 101:18129-18134.
170. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Ramakrishna S. Poly(Glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of myocardial infarction. Tissue Eng Part A. 2011, 17:1363-1373.
171. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Sridhar R., Ramakrishna S. Expression of cardiac proteins in neonatal cardiomyocytes on PGS/fibrinogen core/shell substrate for Cardiac tissue engineering. Int J Cardiol. 2013, 167:1461-1468.
172. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Sridhar R., Ramakrishna S. Minimally invasive injectable short nanofibers of poly(glycerol sebacate) for cardiac tissue engineering. Nanotechnology. 2012, 23:385102.
173. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation. 1999, 100:193-202.
174. Reiss K., Capasso J.M., Huang H.E., Meggs L.G., Li P., Anversa P. ANGII receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am J Physiol. 1993, 264:H760-H769.
175. Rosano G.M., Fini M., Caminiti G., Barbaro G. Cardiac metabolism in myocardial ischemia. Curr Pharm Des. 2008, 14:2551-2562.
176. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993, 73:413-423.
177. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993, 75:977-984.
178. Saif J., Schwarz T.M., Chau D.Y., Henstock J., Sami P., et al. Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol. 2010, 30:1897-1904.
179. Sarig U., Machluf M. Engineering cell platforms for myocardial regeneration. Expert Opin Biol Ther. 2011, 11:1055-1077.
180. Sartipy U., Albage A., Lindblom D. The Dor procedure for left ventricular reconstruction. Ten-year clinical experience. Eur J Cardiothorac Surg. 2005, 27:1005-1010.
181. Sartipy U., Albage A., Lindblom D. The Dor procedure for left ventricular reconstruction. Ten-year clinical experience. Eur J Cardio-Thor Surg. 2005, 27:1005-1010.
182. Sasagawa T., Shimizu T., Sekiya S., Haraguchi Y., Yamato M., et al. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials. 2010, 31:1646-1654.
183. Sawa Y. Myocardial regeneration for heart failure. Nippon Rinsho 2010, 68:719-725.
184. Sawa Y. [Myocardial regeneration for heart failure]. Nippon Rinsho. Jpn J Clin Med 2010, 68:719-725.
185. Schmidt C.E., Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials. 2000, 21:2215-2231.
186. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature. 2008, 451:937-942.
187. Seif-Naraghi S.B., Salvatore M.A., Schup-Magoffin P.J., Hu D.P., Christman K.L. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A. 2010, 16:2017-2027.
188. Sekine H., Shimizu T., Hobo K., Sekiya S., Yang J., et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation. 2008, 118:S145-S152.
189. Serradifalco C., Catanese P., Rizzuto L., Cappello F., Puleio R., et al. Embryonic and foetal Islet-1 positive cells in human hearts are also positive to c-Kit. Eur J Histochem. 2011, 55:e41.
190. Severs N.J. The cardiac muscle cell. Bioessays. 2000, 22:188-199.
191. Shafy A., Fink T., Zachar V., Lila N., Carpentier A., Chachques J.C. Development of cardiac support bioprostheses for ventricular restoration and myocardial regeneration. Eur J Cardiothorac Surg. 2013, 43:1211-1219.
192. Shamhart P.E., Meszaros J.G. Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling?. J Mol Cell Cardiol. 2010, 48:530-537.
193. Sherman W. Myocyte replacement therapy: skeletal myoblasts. Cell Transplant. 2007, 16:971-975.
194. Shimizu T., Sekine H., Isoi Y., Yamato M., Kikuchi A., Okano T. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng. 2006, 12:499-507.
195. Shimizu T., Sekine H., Yamato M., Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des. 2009, 15:2807-2814.
196. Shimizu T., Yamato M., Kikuchi A., Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials. 2003, 24:2309-2316.
197. Shin M., Ishii O., Sueda T., Vacanti J.P. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials. 2004, 25:3717-3723.
198. Simpson D.L., Dudley S.C. Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction. J Tissue Eng Regen Med. 2013, 7:192-202.
199. Singelyn J.M., Christman K.L. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res. 2010, 3:478-486.
200. Singelyn J.M., Dequach J.A., Seif-Naraghi S.B., Littlefield R.B., Schup-Magoffin P.J., Christman K.L. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials. 2009, 30:5409-5416.
201. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007, 115:896-908.
202. Spinale F.G. Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences. Circulation. 2011, 124:2052-2055.
203. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008, 322:945-949.
204. Stankus J.J., Guan J., Fujimoto K., Wagner W.R. Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials. 2006, 27:735-744.
205. Stankus J.J., Guan J., Wagner W.R. Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. J Biomed Mater Res A. 2004, 70:603-614.
206. Stevens K.R., Kreutziger K.L., Dupras S.K., Korte F.S., Regnier M., et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 2009, 106:16568-16573.
207. Stevens K.R., Pabon L., Muskheli V., Murry C.E. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A. 2009, 15:1211-1222.
208. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000, 101:2981-2988.
209. Suzuki R., Hattori F., Itabashi Y., Yoshioka M., Yuasa S., et al. Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun. 2009, 387:353-359.
210. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126:663-676.
211. Takehara N., Tsutsumi Y., Tateishi K., Ogata T., Tanaka H., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008, 52:1858-1865.
212. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature. 2009, 459:708-711.
213. Tan L.B., Jalil J.E., Pick R., Janicki J.S., Weber K.T. Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 1991, 69:1185-1195.
214. Tandon N., Cannizzaro C., Chao P.H., Maidhof R., Marsano A., et al. Electrical stimulation systems for cardiac tissue engineering. Nat Protoc. 2009, 4:155-173.
215. Tang X.L., Rokosh G., Sanganalmath S.K., Yuan F., Sato H., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010, 121:293-305.
216. Theisen C., Fuchs-Winkelmann S., Knappstein K., Efe T., Schmitt J., et al. Influence of nanofibers on growth and gene expression of human tendon derived fibroblast. Biomed Eng Online. 2010, 9:9.
217. Tous E., Purcell B., Ifkovits J.L., Burdick J.A. Injectable acellular hydrogels for cardiac repair. J Cardiovasc Transl Res. 2011, 4:528-542.
218. Tran N., Li Y., Maskali F., Antunes L., Maureira P., et al. Short-term heart retention and distribution of intramyocardial delivered mesenchymal cells within necrotic or intact myocardium. Cell Transplant. 2006, 15:351-358.
219. Tsur-Gang O., Ruvinov E., Landa N., Holbova R., Feinberg M.S., et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials. 2009, 30:189-195.
220. Vozzi G., Previti A., De Rossi D., Ahluwalia A. Microsyringe-based deposition of two-dimensional and three-dimensional polymer scaffolds with a well-defined geometry for application to tissue engineering. Tissue Eng. 2002, 8:1089-1098.
221. Vunjak-Novakovic G., Tandon N., Godier A., Maidhof R., Marsano A., et al. Challenges in cardiac tissue engineering. Tissue Eng Part B Rev. 2010, 16:169-187.
222. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635.
223. Wall S.T., Yeh C.C., Tu R.Y., Mann M.J., Healy K.E. Biomimetic matrices for myocardial stabilization and stem cell transplantation. J Biomed Mater Res A. 2010, 95:1055-1066.
224. Wang B., Borazjani A., Tahai M., Curry A.L., Simionescu D.T., et al. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A. 2010, 94:1100-1110.
225. Wang F., Li Z., Khan M., Tamama K., Kuppusamy P., et al. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater. 2010, 6:1978-1991.
226. Wang H., Zhang X., Li Y., Ma Y., Zhang Y., et al. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant. 2010, 29:881-887.
227. Wang T., Jiang X.J., Tang Q.Z., Li X.Y., Lin T., et al. Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater. 2009, 5:2939-2944.
228. Wang T., Wu D.Q., Jiang X.J., Zhang X.Z., Li X.Y., et al. Novelthermosensitive hydrogel injection inhibits post-mfarct ventricle remodelling. Eur J Heart Fail. 2009, 11:14-19.
229. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010, 7:618-630.
230. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989, 13:1637-1652.
231. Weber K.T., Pick R., Silver M.A., Moe G.W., Janicki J.S., et al. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation. 1990, 82:1387-1401.
232. Weisman H.F., Bush D.E., Mannisi J.A., Bulkley B.H. Global cardiac remodeling after acute myocardial infarction: a study in the rat model. J Am Coll Cardiol. 1985, 5:1355-1362.
233. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987, 76:44-51.
234. Wohrle J., Merkle N., Mailander V., Nusser T., Schauwecker P., et al. Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol. 2010, 105:804-812.
235. Wu K., Liu Y.L., Cui B., Han Z. Application of stem cells for cardiovascular grafts tissue engineering. Transpl Immunol. 2006, 16:1-7.
236. Xiong Q., Hill K.L., Li Q., Suntharalingam P., Mansoor A., et al. A fibrin patch- based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells. 2011, 29:367-375.
237. Xu H., Yi B.A., Wu H., Bock C., Gu H., et al. Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res. 2012, 22:142-154.
238. Yamamoto T., Suto N., Okubo T., Mikuniya A., Hanada H., et al. Intramyocardial delivery of basic fibroblast growth factor-impregnated gelatin hydrogel microspheres enhances collateral circulation to infarcted canine myocardium. Jpn Circ J. 2001, 65(43):9-44.
239. Yildirim Y., Naito H., Didie M., Karikkineth B.C., Biermann D., et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation. 2007, 116:I16-I23.
240. Yoon S.J., Fang Y.H., Lim C.H., Kim B.S., Son H.S., et al. Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. J Biomed Mater Res B Appl Biomater. 2009, 91:163-171.
241. Yu J., Christman K.L., Chin E., Sievers R.E., Saeed M., Lee R.J. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2009, 137:180-187.
242. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials. 2010, 31:7012-7020.
243. Zamilpa R., Lindsey M.L. Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J Mol Cell Cardiol. 2010, 48:558-563.
244. Zavadzkas J.A., Mukherjee R., Rivers W.T., Patel R.K., Meyer E.C., et al. Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling. Am J Physiol Heart Circ Physiol. 2011, 301:H1656-H1666.
245. Zeng L., Hu Q., Wang X., Mansoor A., Lee J., et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation. 2007, 115:1866-1875.
246. Zhang G., Wang X., Wang Z., Zhang J., Suggs L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng. 2006, 12:9-19.
247. Zhang J., Ding L., Zhao Y., Sun W., Chen B., et al. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation. 2009, 119:1776-1784.
248. Zhang S., Guo J., Zhang P., Liu Y., Jia Z., et al. Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats. Life Sci. 2004, 74:2853-2864.
249. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011, 474:212-215.
250. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006, 12:452-458.
251. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002, 90:223-230.
252. Zuba-Surma E.K., Guo Y., Taher H., Sanganalmath S.K., Hunt G., et al. Transplantation of expanded bone marrow-derived very small embryonic-hke stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med. 2011, 15:1319-1328.